- Home
- GH vs CSW Comparison
GH vs CSW Comparison
Compare GH & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- CSW
- Stock Information
- Founded
- GH 2011
- CSW 2014
- Country
- GH United States
- CSW United States
- Employees
- GH N/A
- CSW N/A
- Industry
- GH Medical Specialities
- CSW Home Furnishings
- Sector
- GH Health Care
- CSW Industrials
- Exchange
- GH Nasdaq
- CSW Nasdaq
- Market Cap
- GH 4.9B
- CSW 5.2B
- IPO Year
- GH 2018
- CSW N/A
- Fundamental
- Price
- GH $49.14
- CSW $281.95
- Analyst Decision
- GH Strong Buy
- CSW
- Analyst Count
- GH 20
- CSW 0
- Target Price
- GH $54.35
- CSW N/A
- AVG Volume (30 Days)
- GH 2.2M
- CSW 93.2K
- Earning Date
- GH 08-06-2025
- CSW 07-30-2025
- Dividend Yield
- GH N/A
- CSW 0.10%
- EPS Growth
- GH N/A
- CSW 28.53
- EPS
- GH N/A
- CSW 8.38
- Revenue
- GH $773,996,000.00
- CSW $878,301,000.00
- Revenue This Year
- GH $23.14
- CSW $22.74
- Revenue Next Year
- GH $21.42
- CSW $7.24
- P/E Ratio
- GH N/A
- CSW $33.60
- Revenue Growth
- GH 28.20
- CSW 10.78
- 52 Week Low
- GH $20.14
- CSW $278.40
- 52 Week High
- GH $52.92
- CSW $313.48
- Technical
- Relative Strength Index (RSI)
- GH 62.17
- CSW N/A
- Support Level
- GH $48.00
- CSW N/A
- Resistance Level
- GH $51.71
- CSW N/A
- Average True Range (ATR)
- GH 2.67
- CSW 0.00
- MACD
- GH 0.39
- CSW 0.00
- Stochastic Oscillator
- GH 78.60
- CSW 0.00
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About CSW CSW Industrials Inc. Common Stock
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.